These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11264729)

  • 1. Cell transformation induced by hepatitis C virus NS3 serine protease.
    Zemel R; Gerechet S; Greif H; Bachmatove L; Birk Y; Golan-Goldhirsh A; Kunin M; Berdichevsky Y; Benhar I; Tur-Kaspa R
    J Viral Hepat; 2001 Mar; 8(2):96-102. PubMed ID: 11264729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.
    Sakamuro D; Furukawa T; Takegami T
    J Virol; 1995 Jun; 69(6):3893-6. PubMed ID: 7745741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
    Yang SH; Lee CG; Song MK; Sung YC
    Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations at vicinity of catalytic sites of hepatitis C virus NS3 serine protease gene isolated from hepatocellular carcinoma tissue.
    Zemel R; Kazatsker A; Greif F; Ben-Ari Z; Greif H; Almog O; Tur-Kaspa R
    Dig Dis Sci; 2000 Nov; 45(11):2199-202. PubMed ID: 11215739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
    Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
    J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.
    Du GX; Hou LH; Guan RB; Tong YG; Wang HT
    World J Gastroenterol; 2002 Dec; 8(6):1088-93. PubMed ID: 12439931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    Yang CM; Yoon JC; Park JH; Lee JM
    PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
    Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
    J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein.
    He QQ; Cheng RX; Sun Y; Feng DY; Chen ZC; Zheng H
    World J Gastroenterol; 2003 Mar; 9(3):474-8. PubMed ID: 12632500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
    Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
    Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
    Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
    Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS
    Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
    Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
    Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
    Zhang J; Ishigaki Y; Takegami T
    Mol Med Rep; 2015 Oct; 12(4):5109-15. PubMed ID: 26151503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
    Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
    Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
    Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
    J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 N-terminal protein].
    He QQ; Cheng RX; Sun Y; Feng DY; Zheng H
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):255-9. PubMed ID: 12882694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virus.
    Filocamo G; Pacini L; Migliaccio G
    J Virol; 1997 Feb; 71(2):1417-27. PubMed ID: 8995667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.
    Mao HX; Lan SY; Hu YW; Xiang L; Yuan ZH
    World J Gastroenterol; 2003 Nov; 9(11):2474-9. PubMed ID: 14606079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
    Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
    Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.